Related references
Note: Only part of the references are listed.Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study
Janet Bee et al.
THORAX (2018)
NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension
Andriy O. Samokhin et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
The suppression of bromodomain and extra-terminal domain inhibits vascular inflammation by blocking NF-κB and MAPK activation
Mingcheng Huang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
The Essential Role of Pin1 via NF-κB Signaling in Vascular Inflammation and Atherosclerosis in ApoE-/- Mice
Ming Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery-jugular vein shunt pulmonary hypertension rat model
Xiaofan Ma et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2017)
A concise review of the bioanalytical methods for the quantitation of sitagliptin, an important dipeptidyl peptidase-4 (DPP4) inhibitor, utilized for the characterization of the drug
P. S. Suresh et al.
BIOMEDICAL CHROMATOGRAPHY (2016)
Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension
Reza Aghamohammadzadeh et al.
FASEB JOURNAL (2016)
Chronic Normobaric Hypoxia Induces Pulmonary Hypertension in Rats: Role of NF-κB
Junming Fan et al.
HIGH ALTITUDE MEDICINE & BIOLOGY (2016)
Novel binding patterns between ganoderic acids and neuraminidase: Insights from docking, molecular dynamics and MM/PBSA studies
Zhiwei Yang et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2016)
Tormentic acid inhibits H2O2-induced oxidative stress and inflammation in rat vascular smooth muscle cells via inhibition of the NF-κB signaling pathway
Yu-Lun Wang et al.
MOLECULAR MEDICINE REPORTS (2016)
Challenges and opportunities in treating inflammation associated with pulmonary hypertension
Norbert F. Voelkel et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2016)
The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes
Steven C. Pugliese et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension
Lin Deng et al.
CIRCULATION RESEARCH (2015)
Computational Design and Discovery of Nanomolar Inhibitors of IκB Kinase β
Hwangseo Park et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Profiling the role of mammalian target of rapamycin in the vascular smooth muscle metabolome in pulmonary arterial hypertension
Tatiana V. Kudryashova et al.
PULMONARY CIRCULATION (2015)
A Critical Role of the mTOR/eIF2α Pathway in Hypoxia-Induced Pulmonary Hypertension
Ai-ping Wang et al.
PLOS ONE (2015)
Nuclear Factor κB Inhibition Reduces Lung Vascular Lumen Obliteration in Severe Pulmonary Hypertension in Rats
Daniela Farkas et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Targeting cell motility in pulmonary arterial hypertension
Roxane Paulin et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Molecular Dynamics Studies of the Protein-Protein Interactions in Inhibitor of κB Kinase-β
Michael R. Jones et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension
Amal Houssaini et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Sander Pronk et al.
BIOINFORMATICS (2013)
Crystal Structure of a Human IκB Kinase β Asymmetric Dimer
Shenping Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mutation effects of neuraminidases and their docking with ligands: a molecular dynamics and free energy calculation study
Zhiwei Yang et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Structure Based Lead Optimization Approach in Discovery of Selective DPP4 Inhibitors
Manjunath Ghate et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
mTOR kinase structure, mechanism and regulation
Haijuan Yang et al.
NATURE (2013)
Tanshinone IIA Inhibits Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation via Akt/Skp2/p27-Associated Pathway
Ying Luo et al.
PLOS ONE (2013)
Nuclear Factor κ-B Is Activated in the Pulmonary Vessels of Patients with End-Stage Idiopathic Pulmonary Arterial Hypertension
Laura C. Price et al.
PLOS ONE (2013)
Permit allocation in emissions trading using the Boltzmann distribution
Ji-Won Park et al.
PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS (2012)
mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia
Vera P. Krymskaya et al.
FASEB JOURNAL (2011)
Multi-Timescale Dynamics Study of FKBP12 Along the Rapamycin-mTOR Binding Coordinate
Paul J. Sapienza et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Simvastatin has beneficial effect on pulmonary artery hypertension by inhibiting NF-κB expression
Zhong-qiang Liu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
CHARMM: The Biomolecular Simulation Program
B. R. Brooks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Identification of a ligand-induced transient refractory period in nuclear factor-κB signaling
Britney L. Moss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-κB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin
Bysani Chandrasekar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
RDOCK: Refinement of rigid-body protein docking predictions
L Li et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2003)
ZDOCK: An initial-stage protein-docking algorithm
R Chen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2003)
Rapamycin in cardiovascular medicine
PN Ruygrok et al.
INTERNAL MEDICINE JOURNAL (2003)
NF-κB is required for TNF-α-directed smooth muscle cell migration
ZB Wang et al.
FEBS LETTERS (2001)
Share Paper
